Soligenix
SNGX
#10619
Rank
ยฃ2.61 M
Marketcap
ยฃ0.25
Share price
0.00%
Change (1 day)
-82.43%
Change (1 year)

EPS for Soligenix (SNGX)

EPS in 2025 (TTM): -ยฃ2.43

According to Soligenix's latest financial reports the company's current EPS (TTM) is -ยฃ2.39. In 2024 the company made an earnings per share (EPS) of -ยฃ3.67 an increase over its 2023 EPS that were of -ยฃ9.33.

EPS history for Soligenix from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ2.43-33.7%
2024-ยฃ3.67-60.66%
2023-ยฃ9.33-83.55%
2022-ยฃ56.6913.95%
2021-ยฃ49.75-56.03%
2020-ยฃ113.1533.33%
2019-ยฃ84.86-29.41%
2018-ยฃ120.22-41.38%
2017-ยฃ205.0924.73%
2016-ยฃ164.42-69%
2015-ยฃ530.40-6.25%
2014-ยฃ565.75-50.77%
2013-ยฃ1,14975.68%
2012-ยฃ654.1568.18%
2011-ยฃ388.96-69.86%
2010-ยฃ1,291-8.75%
2009-ยฃ1,41433.33%
2008-ยฃ1,061-57.14%
2007-ยฃ2,475-46.15%
2006-ยฃ4,59744.44%
2005-ยฃ3,182-40.7%
2004-ยฃ5,367-15.62%
2003-ยฃ6,361-25.52%
2002-ยฃ8,540-80.94%
2001-ยฃ44,805160.89%
2000-ยฃ17,174-40.57%
1999-ยฃ28,896-63.84%
1998-ยฃ79,913601.73%
1997-ยฃ11,388101.7%
1996-ยฃ5,646

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ8.21-443.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ1.00-141.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.52-163.74%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-ยฃ0.70-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ1.50-37.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.91-138.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Emergent BioSolutions
EBS
ยฃ1.04-143.52%๐Ÿ‡บ๐Ÿ‡ธ USA